Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate from ▲Subject
 18.6.2026Viatris Limited (VIM)0287AOlanzapin Viatris 10 mg orodispergovateľné tablety (tbl oro 28x1x10 mg (blis.OPA/Al/PVC/Al))31.8.2026Z
 10.7.2026Teva B.V. (TEV-NL-4)09292Ramipril Actavis 10 mg (tbl 98x10 mg (blis.Al/Al))30.8.2026R
 10.7.2026Actavis Group PTC ehf. (ACT-10)0162APioglitazone Actavis 30 mg tablety (tbl 28x30 mg (blis.Al/Al))30.8.2026R
 4.8.2026TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)5510DDeferasirox Teva 360 mg filmom obalené tablety (tbl flm 30x1x360 mg (blis.Al/PVC/PE/PVDC-jednotliv.dáv.))30.8.2026Z
 1.7.2026Teva B.V. (TEV-NL-4)66180Valsartan HCT Teva 160/25 mg (tbl flm 28x160 mg/25 mg (blis.PVC/PE/PVDC/Al))30.8.2026R
 1.7.2026Teva B.V. (TEV-NL-4)1236ARaponer 4 mg (tbl plg 84x4 mg (blis.Al/Al))28.8.2026R
 12.8.2026Teva B.V. (TEV-NL-4)0055FGabapentin Teva B.V. 100 mg (cps dur 100x100 mg (blis.PVC/PVdC//Al))27.8.2026R
 24.6.2026TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)8596DPaliperidón Teva 75 mg injekčná suspenzia s predĺženým uvoľňovaním (sus ijp 1x75 mg (striek.inj.napln.+2x ihla))25.8.2026R
 17.7.2026TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)8003EApremilast Teva 10 mg, Apremilast Teva 20 mg, Apremilast Teva 30 mg (tbl flm 27 (4x10 mg + 4x20 mg + 19x30 mg) - (blis.PVC/PCTFE/PVC/Al) - zač. liečba)24.8.2026R
 17.7.2026TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)3381AEplerenone Teva 50 mg (tbl flm 30x1x50 mg (blis.PVC/PVDC/Al perf.))24.8.2026R
 23.7.2026PIERRE FABRE MEDICAMENT (PFB-FR-1)66805Tardyferon-Fol (tbl plg 30 (blis.Al/PVC/PVDC))24.8.2026R
 1.7.2026TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)84127HERPESIN 200 (tbl 25x200 mg (blis.PVC/Al))23.8.2026R
 24.7.2026Biosimilar Collaborations Ireland Limited (BTT)9177CHulio 40 mg injekčný roztok v naplnenom pere (sol inj 2x0,8 ml/40 mg (pero napl.plast.+2 tamp.))20.8.2026R
 30.7.2026Viatris Limited (VIM)95320Tamsulosin HCl Viatris 0,4 mg (cps mdd 100x0,4 mg (blis.PVC/PE/PVDC/Al))20.8.2026Z
 24.7.2026Pfizer Europe MA EEIG (PFI-BE-3)09711SOLU-MEDROL 500 mg (plv iol 1x500 mg+1x7,8 ml solv. (1x liek.inj.+1x liek.inj.))17.8.2026R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)